PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer

Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial

(2014) Edward Partridge et al.   OBSTETRICS AND GYNECOLOGY

Precursor lesions of early onset pancreatic cancer

(2011) Łukasz Liszka et al.   VIRCHOWS ARCHIV

Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?

(2010) Christopher G. Przybycin et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Joint Loss of PAX2 and PTEN Expression in Endometrial Precancers and Cancer

(2010) N. M. Monte et al.   CANCER RESEARCH

Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers

(2010) Danielle Vicus et al.   GYNECOLOGIC ONCOLOGY

The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls

(2010) Karishma K Mehra et al.   MODERN PATHOLOGY

High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression

(2010) Michael H Roh et al.   MODERN PATHOLOGY

HMGA2: A Potential Biomarker Complement to P53 for Detection of Early-stage High-grade Papillary Serous Carcinoma in Fallopian Tubes

(2009) Jian-Jun Wei et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

PAX 2: A Novel Müllerian Marker for Serous Papillary Carcinomas to Differentiate From Micropapillary Breast Carcinoma

(2009) Mamatha Chivukula et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers

(2009) Patricia A Shaw et al.   MODERN PATHOLOGY

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

(2009) Celestine S Tung et al.   MODERN PATHOLOGY

Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma

(2008) Shannon Salvador et al.   GYNECOLOGIC ONCOLOGY